Capsule filling is a complex process, and the product to be encapsulated must be well developed to ensure mass uniformity. Iñaki Bueno, formulation and manufacturing manager at Idifarma, and Rob ...

Advancements in soft capsule technology can enable the development of soft capsule formulations, which are becoming the preferred method of oral administration. Soft capsule formulation technology ...

DUBLIN--(BUSINESS WIRE)--The "Capsule Endoscopy Market to 2027 - Global Analysis and Forecasts by Product; Formulation; End Users, and Geography" report has been added to ResearchAndMarkets.com's ...

Fagron, the leading global player in pharmaceutical compounding, launches DiluCap, a new line of six excipients for compounding pharmacies allowing for easier and faster capsule formulation. Choosing ...

LYON, France--(BUSINESS WIRE)--MaaT Pharma announced today that it treated its first patient in a Phase 1 clinical trial to evaluate the safety and tolerability of MaaT033, a capsule formulation of ...

Increasing clarithromycin resistance is dramatically reducing the efficacy of standard triple therapy for Helicobacter pylori eradication. Quadruple therapy is associated with high cure rates, yet its ...

Objective: Spalt-Liqua® is a newsoft gelatin capsule containing 200mg of totally dissolved ibuprofen as the active ingredient. The primary objective of the study was to assess bioequivalence between ...

June 9, 2005 — The U.S. Food and Drug Administration (FDA) has approved a capsule formulation of paricalcitol for the prevention and treatment of secondary hyperparathyroidism in patients with stage ...

The tablet formulation of Brukinsa is supplied as a 160mg dose, allowing patients the convenience of taking only 2 tablets daily. The Food and Drug Administration (FDA) has approved a new tablet ...

IIIM functions under the Council of Scientific and Industrial Research (CSIR). The Indian Institute of Integrative Medicine (IIIM) here on Wednesday said it has developed a capsule formulation from ...

Shire announced that it has submitted to the Food and Drug Administration (FDA) a New Drug Application (NDA) for a new, alternate formulation of Vyvanse (lisdexamfetamine dimesylate) as a chewable ...